Opko Health, Inc. - Common Stock (OPK)

It posted a beat-and-raise second quarter.

Gainers OPKO Health (NASDAQ:OPK) shares increased by 34.7% to $1.67 during Tuesday's regular session. The company's market cap stands at $936.3 million. As per the press release, Q2 earnings came out yesterday.

OPKO Health (NASDAQ:OPK) reported a narrower second-quarter loss as gains tied to its diagnostics restructuring and a China commercialization agreement helped lift revenue, while the company continued to increase investment in clinical development programs. Total revenue for the second quarter of 2

OPKO Health (OPK) Q4 2025 Earnings Call Transcript

OPKO Health Q3 2025 earnings beat estimates with a surprise profit, driving a positive market reaction despite a revenue miss.

OPKO Health's Q2 2025 earnings missed revenue and EPS estimates, causing a 7.8% stock drop. Weak performance in pharma/diagnostics segments and higher losses raised investor concerns.

Late Friday, the company said the U.S.-China tariffs will have a material impact on anticipated sales of U.S. products into China.

OPK earnings call for the period ending December 31, 2024.